REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 104,986,330
- Total 13F shares
- 89,209,869
- Share change
- -2,558,432
- Total reported value
- $46,858,212,368
- Put/Call ratio
- 86%
- Price per share
- $525.00
- Number of holders
- 1,192
- Value change
- -$1,426,702,234
- Number of buys
- 564
- Number of sells
- 674
Quarterly Holders Quick Answers
What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75886F107:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
9%
|
9,407,891
|
$5,966,766,709 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.5%
|
8,925,880
|
$5,661,061,035 | — | 31 Mar 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
3.2%
from 13D/G
|
7,598,584
|
$4,819,250,174 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
5,658,197
|
$3,588,599,008 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
4,789,659
|
$3,037,745,428 | — | 31 Mar 2025 | |
| Capital International Investors |
13F
|
Company |
3.8%
|
3,989,132
|
$2,530,196,274 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,469,585
|
$1,561,215,426 | — | 31 Mar 2025 | |
| DODGE & COX |
13F
|
Company |
2.2%
|
2,324,085
|
$1,474,004,430 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2.2%
|
2,276,675
|
$1,443,935,585 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
2,175,026
|
$1,379,467,000 | — | 31 Mar 2025 | |
| Capital World Investors |
13F
|
Company |
1.8%
|
1,938,634
|
$1,229,562,992 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.6%
|
1,635,981
|
$1,037,588,000 | — | 31 Mar 2025 | |
| Amundi |
13F
|
Individual |
1.5%
|
1,603,901
|
$979,793,610 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,250,954
|
$793,394,703 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.99%
|
1,044,237
|
$662,286,388 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
1,001,750
|
$635,339,903 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.9%
|
940,336
|
$596,389,300 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.81%
|
850,746
|
$539,568,913 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.8%
|
837,093
|
$530,909,507 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.71%
|
747,033
|
$473,790,739 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.71%
|
746,613
|
$473,524,363 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.69%
|
722,467
|
$458,210,992 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.67%
|
706,440
|
$448,045,441 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.67%
|
702,892
|
$445,795,193 | — | 31 Mar 2025 | |
| VAGELOS P ROY |
3/4/5
|
Director |
—
class O/S missing
|
467,104
|
$444,337,350 | — | 03 Apr 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.67%
|
698,253
|
$442,852,999 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.58%
|
609,608
|
$386,631,682 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.55%
|
578,889
|
$367,148,770 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.54%
|
571,187
|
$362,268,098 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.53%
|
553,800
|
$351,236,574 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.52%
|
543,092
|
$344,445,239 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.52%
|
542,018
|
$343,764,077 | — | 31 Mar 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.51%
|
532,214
|
$337,551,000 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.46%
|
481,389
|
$305,311,345 | — | 31 Mar 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.45%
|
473,450
|
$300,276,194 | — | 31 Mar 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.42%
|
436,508
|
$276,846,309 | — | 31 Mar 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.39%
|
407,370
|
$258,366,275 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.38%
|
398,236
|
$252,574,364 | — | 31 Mar 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.37%
|
389,598
|
$246,608,984 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.35%
|
372,071
|
$235,978,590 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.34%
|
351,887
|
$223,177,292 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.32%
|
340,145
|
$215,570,684 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.31%
|
321,357
|
$203,814,251 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
304,800
|
$193,313,304 | — | 31 Mar 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.29%
|
303,669
|
$192,595,990 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.29%
|
300,956
|
$191,204,731 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.27%
|
287,163
|
$182,127,388 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.27%
|
284,003
|
$180,123,223 | — | 31 Mar 2025 | |
| National Pension Service |
13F
|
Company |
0.24%
|
253,046
|
$160,489,365 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.23%
|
245,197
|
$155,647,378 | — | 31 Mar 2025 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q2 2025
As of 30 Jun 2025,
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by
1,192 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,209,869 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, JPMORGAN CHASE & CO, Dodge & Cox, FMR LLC, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, and Capital World Investors.
This page lists
1,195
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
1,275
Q2 2025 holders
1,192
Holder diff
-83
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.